Abstract:Cytopenias are a common occurrence due to abnormal hematopoiesis persistent in patients suffering from and advancing with HIV/AIDS. In order to develop efficacious therapies against cytopenias, it is necessary to understand the mechanisms by which HIV infection affects the differentiation of hematopoietic stem-progenitor cells (HSPCs), causing hematopoietic inhibition, that leads to hematological disorders. Currently, only the antiretrovirals that are being used to treat HIV infection and indirectly lower the levels of virus replication also co-attenuate cytopenias. The evidence available suggests that this indirect efficacy may not prevail for the lifetime of the infected patients, and the acquired immunodeficiency can overtake the beneficial consequences of decreased virus replication. As cited in this article, we and our colleagues are the first to make a foray into the involvement of microRNAs and their use as potential interventional treatments for the cytopenias that occur with HIV/AIDS. Herein, we progressed further in the direction of the mechanisms of the involvement of homeobox gene regulation to cause cytopenias. We had previously shown that HIV-1 inhibits multi-lineage hematopoiesis of the CD34 + cells using SCID-hu Thy/Liv animals in vivo . Furthermore, we demonstrated that the virus-induced hematopoietic inhibition occurred despite the CD34 + cells being resistant to HIV-1 infection. We set out to search for the specific host factors secreted by CD4 + T-cells that likely participate in the inhibition of hematopoiesis of the HIV infection-resistant CD34 + cells. More recently, we reported the identification of virus-infected CD4 + thymocyte-secreted miRNA-15a and miRNA-24 and that their differential expression following HIV infection causes the indirect inhibition of hematopoiesis. We then hypothesized that the observed miRNA differential expression in the virus-infected T-cells causes the abnormal regulation of homeobox (HOX) gene-encoded transcriptomes in the CD34 + cells, affecting specific MAPK signaling and CD34 + cell fate, thereby disrupting normal hematopoiesis. We present that in HIV infection, miRNA-mediated post-transcriptional dysregulation of HOXB3 mRNA inhibits multi-lineage hematopoiesis, which translates into hematological disorders in virus-infected patients with HIV/AIDS. These observations portend specific microRNA candidates for potential efficacy against the virus-induced cytopenias that are otherwise not treatable by the existing HAART/ART regimens, which are primarily designed and applicable for the attenuation of virus replication.

MicroRNA target homeobox messenger RNA in HIV induced hematopoietic inhibition

Microrna-155 is A Biomarker of T-Cell Activation and Immune Dysfunction in Hiv-1-Infected Patients

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

The Role of MicroRNAs in HIV Infection

Altered Host microRNAomics in HIV Infections: Therapeutic Potentials and Limitations

HIV-1-related mechanisms of suppression of CD34+ hematopoietic progenitors.

MicroRNAs and exosomes: key players in HIV pathogenesis

Targeting c-Mpl for Revival of Human Immunodeficiency Virus Type 1-Induced Hematopoietic Inhibition When CD34+ Progenitor Cells Are Re-Engrafted into a Fresh Stromal Microenvironment In Vivo

Short Communication: HIV-1 Infection Suppresses Circulating Viral Restriction Micrornas.

Contrasting mechanistic susceptibilities of hematopoietic and endothelial stem-progenitor cells in respective pathogeneses of HIV-1 and SARS-CoV-2 infections

High-throughput Sequencing Identifies HIV-1-replication- and Latency-Related Mirnas in CD4+ T Cell Lines.

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4 + T lymphocytes

Regulation of Human Immunodeficiency Virus Type 1 Infection, Β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry

Biological function of microRNA in HIV-1 infection:summary of recent progress

Circular RNA Profiles in Viremia and ART Suppression Predict Competing circRNA–miRNA–mRNA Networks Exclusive to HIV-1 Viremic Patients

HIV-1-Induced miR-146a Attenuates Monocyte Migration by Targeting CCL5 in Human Primary Macrophages

MicroRNA Mir-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection.

Two Cellular Micrornas, Mir-196B and Mir-1290, Contribute to HIV-1 Latency

Profiles of MicroRNAs in Interleukin-27-Induced HIV-Resistant T Cells: Identification of a Novel Antiviral MicroRNA

Suppression of Active HIV-1 Infection in CD34+ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs

MicroRNA Expression Profiling of Intestinal Mucosa Tissue Predicts Multiple Crucial Regulatory Molecules and Signaling Pathways for Gut Barrier Dysfunction of AIDS Patients.